yourstate.us
20 CFR 30.709

§ 30.709 How are payments for medicinal drugs determined?

United States · 20 CFR — Employees' Benefits · Status: effective

Get this as JSONEmbed this
Cite this
Citation
20 CFR 30.709, § 30.709 How are payments for medicinal drugs determined?, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/76821
Permanent ID
ys:prov:76821@1
SHA-256
caaa3520647cb6b9aeb1d7cde2724f153c3273a7ffb022f1af064c8df0cb6b31

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

Unless otherwise specified by OWCP, payment for medicinal drugs prescribed by physicians shall not exceed the amount derived by multiplying the average wholesale price of the medication by the quantity or amount provided, plus a dispensing fee. OWCP may, in its discretion, contract for or require the use of specific providers for certain medications. (a) All prescription medications identified by NDC number will be assigned an average wholesale price representing the product's nationally recognized wholesale price as determined by surveys of manufacturers and wholesalers. OWCP will establish the dispensing fee, which will not be affected by the location or type of provider dispensing the medication. (b) The NDC numbers, the average wholesale prices, and the dispensing fee shall be reviewed from time to time and updated as necessary. (c) With respect to prescribed medications, OWCP may require the use of generic equivalents where they are available.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.